These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
203 related articles for article (PubMed ID: 30284508)
1. Are anticoagulants still indicated in pulmonary arterial hypertension? Olschewski H; Rich S Pulm Circ; 2018; 8(4):2045894018807681. PubMed ID: 30284508 [TBL] [Abstract][Full Text] [Related]
2. Anticoagulation in Pulmonary Arterial Hypertension. Robinson JC; Pugliese SC; Fox DL; Badesch DB Curr Hypertens Rep; 2016 Jun; 18(6):47. PubMed ID: 27137522 [TBL] [Abstract][Full Text] [Related]
3. Anticoagulation and survival in pulmonary arterial hypertension: results from the Comparative, Prospective Registry of Newly Initiated Therapies for Pulmonary Hypertension (COMPERA). Olsson KM; Delcroix M; Ghofrani HA; Tiede H; Huscher D; Speich R; Grünig E; Staehler G; Rosenkranz S; Halank M; Held M; Lange TJ; Behr J; Klose H; Claussen M; Ewert R; Opitz CF; Vizza CD; Scelsi L; Vonk-Noordegraaf A; Kaemmerer H; Gibbs JS; Coghlan G; Pepke-Zaba J; Schulz U; Gorenflo M; Pittrow D; Hoeper MM Circulation; 2014 Jan; 129(1):57-65. PubMed ID: 24081973 [TBL] [Abstract][Full Text] [Related]
4. Indications and potential pitfalls of anticoagulants in pulmonary hypertension: Would DOACs become a better option than VKAs? Margelidon-Cozzolino V; Delavenne X; Catella-Chatron J; De Magalhaes E; Bezzeghoud S; Humbert M; Montani D; Bertoletti L Blood Rev; 2019 Sep; 37():100579. PubMed ID: 31113643 [TBL] [Abstract][Full Text] [Related]
5. Impact on survival of warfarin in patients with pulmonary arterial hypertension receiving subcutaneous treprostinil. Ascha M; Zhou X; Rao Y; Minai OA; Tonelli AR Cardiovasc Ther; 2017 Oct; 35(5):. PubMed ID: 28643420 [TBL] [Abstract][Full Text] [Related]
6. Anticoagulation in Pulmonary Arterial Hypertension: Do We Know the Answer? Rawal H; Suman A; Bhoite RR; Kanwal A; Young RK; Aronow WS; Lavie C; Ghosh RK Curr Probl Cardiol; 2021 Mar; 46(3):100738. PubMed ID: 33250263 [TBL] [Abstract][Full Text] [Related]
7. Anticoagulation in patients with pulmonary arterial hypertension: An update on current knowledge. Roldan T; Landzberg MJ; Deicicchi DJ; Atay JK; Waxman AB J Heart Lung Transplant; 2016 Feb; 35(2):151-64. PubMed ID: 26527532 [TBL] [Abstract][Full Text] [Related]
8. Effect of Warfarin Treatment on Survival of Patients With Pulmonary Arterial Hypertension (PAH) in the Registry to Evaluate Early and Long-Term PAH Disease Management (REVEAL). Preston IR; Roberts KE; Miller DP; Sen GP; Selej M; Benton WW; Hill NS; Farber HW Circulation; 2015 Dec; 132(25):2403-11. PubMed ID: 26510696 [TBL] [Abstract][Full Text] [Related]
14. Complications associated with the use of oral anticoagulation in patients with pulmonary arterial hypertension from two referral centers. Roldan T; Rios JJ; Villamañan E; Waxman AB Pulm Circ; 2017; 7(3):692-701. PubMed ID: 28677986 [TBL] [Abstract][Full Text] [Related]
15. Pulmonary arterial hypertension: new insights into the optimal role of current and emerging prostacyclin therapies. Waxman AB; Zamanian RT Am J Cardiol; 2013 Mar; 111(5 Suppl):1A-16A; quiz 17A-19A. PubMed ID: 23414683 [TBL] [Abstract][Full Text] [Related]
16. Anticoagulation in pulmonary arterial hypertension: a qualitative systematic review. Johnson SR; Mehta S; Granton JT Eur Respir J; 2006 Nov; 28(5):999-1004. PubMed ID: 17074918 [TBL] [Abstract][Full Text] [Related]
17. Thrombotic arteriopathy and anticoagulation in pulmonary hypertension. Johnson SR; Granton JT; Mehta S Chest; 2006 Aug; 130(2):545-52. PubMed ID: 16899857 [TBL] [Abstract][Full Text] [Related]